You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Short report
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer

 

Online download statistics by month:

Online download statistics by month: April 2020 to April 2026

AbstractFullPdf
Apr 2020579579371
May 2020326326136
Jun 202016916976
Jul 2020646427
Aug 2020939440
Sep 202010510635
Oct 202010410453
Nov 202011811963
Dec 202013613651
Jan 202118418471
Feb 202118518571
Mar 2021233233115
Apr 202114914949
May 202122822841
Jun 202113313369
Jul 202111011099
Aug 2021111111141
Sep 202112012098
Oct 202112812878
Nov 202112212277
Dec 202113213551
Jan 202215416067
Feb 202211011571
Mar 202214214673
Apr 202214615687
May 202212813565
Jun 202213614062
Jul 202214214764
Aug 202215016672
Sep 2022119123113
Oct 202213514778
Nov 202215315979
Dec 202213113132
Jan 202314614946
Feb 202313814239
Mar 202313113352
Apr 202312512754
May 202313914068
Jun 202311311446
Jul 202311411854
Aug 202312412542
Sep 202310811133
Oct 202312112339
Nov 202315615748
Dec 202321721860
Jan 2024697034
Feb 2024889035
Mar 202414815058
Apr 202410510546
May 2024737634
Jun 2024787949
Jul 20249910123
Aug 202410210234
Sep 2024656741
Oct 202411211732
Nov 202411311543
Dec 202412813248
Jan 202511411748
Feb 202514914942
Mar 2025969854
Apr 2025848525
May 202510110241
Jun 2025676725
Apr 2026110
Total859987403968